Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1058Neoplasms 884Prostatic Neoplasms 510Lung Neoplasms 425Colorectal Neoplasms 359Motor Activity 226Head and Neck Neoplasms 195Uterine Cervical Neoplasms 192Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 175Pancreatic Neoplasms 162Ovarian Neoplasms 141Colonic Neoplasms 138Carcinoma, Hepatocellular 137Anxiety Disorders 124Rectal Neoplasms 119Hematologic Neoplasms 116Multiple Myeloma 109Stomach Neoplasms 104Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Urinary Bladder Neoplasms 88Pain 88Glioblastoma 87Endometrial Neoplasms 87Lymphoma 84Disease 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Rubinstein-Taybi Syndrome × 1 year × Clear all
NCT06740162 2026-02-23

PACE

University of North Carolina, Chapel Hill

Phase NA Recruiting
376 enrolled

Autism Spectrum Disorder, Trisomy 13 Syndrome, Cri-du-Chat Syndrome, De Lange Syndrome, Down Syndrome, Fragile X Syndrome, Intellectual Disability, Motor Activity, Prader-Willi Syndrome, Rubinstein-Taybi Syndrome, WAGR Syndrome, Williams Syndrome, X-Linked Intellectual Disability, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡